759 results on '"Hamano, Takayuki"'
Search Results
2. The impact of low and high dialysate calcium concentrations on cardiovascular disease and death in patients undergoing maintenance hemodialysis: a systematic review and meta-analysis
3. Effectiveness of calcimimetics on fractures in dialysis patients with secondary hyperparathyroidism: meta-analysis of randomized trials
4. Residual kidney function modifies the effect of cinacalcet on serum phosphorus levels among peritoneal dialysis patients
5. Risk Factors for Thromboembolic Events in Patients With Dialysis-Dependent CKD: Pooled Analysis of Phase 3 Roxadustat Trials in Japan
6. Risk Factors for Thromboembolic Events in Patients With Dialysis-Dependent CKD: Pooled Analysis of Four Global Roxadustat Phase 3 Trials
7. Low-dosage active vitamin D modifies the relationship between hypocalcemia and overhydration in patients with advanced chronic kidney disease
8. Body fluid volume calculated using the uric acid kinetic model relates to the vascular event
9. Possible contribution of phosphate to the pathogenesis of chronic kidney disease in dolphins
10. The cisplatin-induced acute kidney injury is a novel risk factor for postoperative complications in patients with esophageal cancer: a retrospective cohort study
11. Mineral and Bone Disorder in CKD
12. Novel anemia therapies in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
13. #653 Changes in iron markers and D-dimer levels during enarodustat treatment depends on different iron prescription patterns in hemodialysis patients
14. Excess risk of cardiovascular events in patients in the United States vs. Japan with chronic kidney disease is mediated mainly by left ventricular structure and function
15. Not baseline but time-dependent erythropoiesis-stimulating agent responsiveness predicts cardiovascular disease in hemodialysis patients receiving epoetin beta pegol: A multicenter prospective PARAMOUNT-HD Study
16. Cardiovascular events by different target hemoglobin levels in ESA-hyporesponsive hemodialysis patients: a multicenter, open-label, randomized controlled study
17. Pre-treatment hematuria and crescents predict estimated glomerular filtration rate trajectory after methylprednisolone pulse therapy with tonsillectomy for IgA nephropathy
18. Mean corpuscular hemoglobin concentration: an anemia parameter predicting cardiovascular disease in incident dialysis patients
19. Relationship of Estimated GFR and Albuminuria to Concurrent Laboratory Abnormalities: An Individual Participant Data Meta-analysis in a Global Consortium
20. Adiposity and risk of decline in glomerular filtration rate: meta-analysis of individual participant data in a global consortium
21. Association of Pre-ESRD Serum Calcium With Post-ESRD Mortality Among Incident ESRD Patients: A Cohort Study.
22. Serum potassium and adverse outcomes across the range of kidney function: a CKD Prognosis Consortium meta-analysis.
23. Skin Perfusion Pressure Outperforms Ankle-Brachial Index in Predicting Mortality and Cardiovascular Outcomes in Hemodialysis Patients
24. The effect of cholecalciferol supplementation on allograft function in incident kidney transplant recipients: A randomized controlled study
25. Controversies in optimal anemia management: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference
26. Electrocardiogram findings at the initiation of hemodialysis and types of subsequent cardiovascular events
27. Pre-dialysis Hyponatremia and Change in Serum Sodium Concentration During a Dialysis Session Are Significant Predictors of Mortality in Patients Undergoing Hemodialysis
28. New Estimation Formulas for Daily Sodium Intake in Hemodialysis Patients by a Duplicate Portion Method
29. Association of Parameters of Mineral Bone Disorder with Mortality in Patients on Hemodialysis according to Level of Residual Kidney Function
30. Lymphocyte Cell Ratios and Mortality among Incident Hemodialysis Patients.
31. Association of kidney transplantation with mortality on hemodialysis after graft failure
32. Maxacalcitol (22-Oxacalcitriol (OCT)) Retards Progression of Left Ventricular Hypertrophy with Renal Dysfunction Through Inhibition of Calcineurin-NFAT Activity
33. Nephrology referral slows the progression of chronic kidney disease, especially among patients with anaemia, diabetes mellitus, or hypoalbuminemia: A single‐centre, retrospective cohort study.
34. Calcimimetics treatment strategy for serum calcium and phosphate management in patients with secondary hyperparathyroidism undergoing dialysis: A systematic review and meta‐analysis of randomized studies.
35. Associations of vitamin D receptor activators and calcimimetics with falls and effect modifications by physical activity: A prospective cohort study on the Japan Dialysis Outcomes and Practice Patterns Study.
36. Low plantar skin perfusion pressure predicts long-term atherosclerotic vascular events and mortality in maintenance haemodialysis patients
37. Hypocalcemia and cardiovascular mortality in cinacalcet users.
38. Lithocholic acid increases intestinal phosphate and calcium absorption in a vitamin D receptor dependent but transcellular pathway independent manner
39. Hypocalcemia and cardiovascular mortality in cinacalcet users
40. Associations of calcium, phosphate and intact parathyroid hormone levels with mortality, residual kidney function and technical failure among patients on peritoneal dialysis
41. Epidemiology and predictors of hyponatremia in a contemporary cohort of patients with malignancy: a retrospective cohort study
42. Long-term excess mortality after hip fracture in hemodialysis patients: a nationwide cohort study in Japan
43. Results of the EPISODE trial plead for reasonable practice-based serum phosphate lowering in patients on dialysis
44. Rate of the “burnt-out diabetes” phenomenon in patients on peritoneal dialysis
45. Association between serum iron markers, iron supplementation and cardiovascular morbidity in pre-dialysis chronic kidney disease.
46. Excess risk of cardiovascular events in patients in the United States vs. Japan with chronic kidney disease is mediated mainly by left ventricular structure and function
47. Novel Anemia Therapies in CKD: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
48. Magnesium and Progression of Chronic Kidney Disease: Benefits Beyond Cardiovascular Protection?
49. Vitamin D and Calcimimetics in Cardiovascular Disease
50. Fibroblast growth factor 23 is not associated with and does not induce arterial calcification
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.